Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant

Transpl Infect Dis. 2018 Aug;20(4):e12899. doi: 10.1111/tid.12899. Epub 2018 May 7.

Abstract

We present a case of possible transfusion-transmitted Ehrlichia chaffeensis infection in a heavily transfused cord blood transplant recipient, resulting in severe infection and graft loss. Transfusion-transmitted, vector-borne infections in immunocompromised individuals can have severe consequences, and should be considered in hospitalized patients receiving blood products with unexplained fever or sepsis.

Keywords: Ehrlichia chaffeensis; blood banks; cord blood transplant; ehrlichiosis; sepsis.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Blood Transfusion*
  • Cord Blood Stem Cell Transplantation / adverse effects*
  • Ehrlichia chaffeensis / isolation & purification*
  • Ehrlichiosis / blood
  • Ehrlichiosis / immunology
  • Ehrlichiosis / microbiology*
  • Ehrlichiosis / transmission
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / microbiology*
  • Graft vs Host Disease / prevention & control
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Leukemia, Myeloid, Acute / surgery
  • Middle Aged
  • Tacrolimus
  • Transplantation Conditioning / adverse effects

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Tacrolimus